Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 6:36 PM
Ignite Modification Date: 2025-12-24 @ 6:36 PM
NCT ID: NCT07218757
Eligibility Criteria: Inclusion Criteria: * Veteran at one of 7 VA healthcare systems; * Age 18 years or older; * At least 3 months of musculoskeletal pain, defined using International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) diagnostic codes, which include the following M-code diagnoses: back pain, fibromyalgia, limb pain, neck pain; R-code diagnoses: pelvic and perineal pain, jaw pain; and G-code diagnoses: tension headaches; and * Pain of at least moderate severity, defined as ≥4 "on average" on the 0-10 Numeric Pain Rating Scale Exclusion Criteria: * Poorly controlled major psychiatric illness (e.g., schizophrenia, bipolar I disorder with acute psychotic symptoms, severe manic or depressive episode listed as active in CPRS); * Active suicide or violence risk (e.g., currently suicidal or homicidal ideation, intent, or plans); * Active severe drug/alcohol use disorder (e.g., drinking more than intended, tried to stop but couldn't, spent significant time drinking or being sick from aftereffects, wanted drink so badly you couldn't think of anything else, interference with home or work life, continued to drink despite problems, given up on activities, dangerous situations, withdrawal and/or tolerance); and * Current participation in CBT-CP or EAET, or participation in either intervention in the last 6 months, via clinical care or another research study.
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Study: NCT07218757
Study Brief:
Protocol Section: NCT07218757